Among the 17 different cancer types examined, gliomas exhibited the highest median FPKM expression levels for PTPRD, followed by colorectal and renal cancers, with values of 3.8 FPKMs, 2.6 FPKMs, and 2.5 FPKMs, respectively. Here, PTPRD is linked to glioma.